AsthmaRESPIRANET-ANCT02901522
Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Telemedicine in Asthma
A study testing telemonitoring, Spirometry (baseline) and Spirometry (20 - 22weeks) in people with Asthma, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
Trial summary
The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with asthma. Read more about this study
- Who is it for?
- Ages 12 to 100 years
- Conditions the study is for
- Asthma
- What is being tested?
- telemonitoring, Spirometry (baseline) and Spirometry (20 - 22weeks)
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteBrazil
- Study dates
- May 2015to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 100 years
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- individual with diagnosis asthma, Asthma Control Test <20, spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster)
Who cannot join
- -low quality spirometries (inadequate)
Trial locations and contacts
1 site in 1 country.
Brazil1 site, 1 recruiting
- Recruiting
TelessaudeRS-Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, 90670000
Cynthia G Molina-Bastos, MD, 5191322585 ext. +55, cyncarol@gmail.com
Marcelo R Gonçalves, PhD, 5191175156 ext. +55, marcelorog@gmail.com
About this study
Official title: Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness.
The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with asthma.
Read the detailed description
This study is a randomized clinical trial for patients with asthma from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of asthma symptoms.
- Conditions
- Asthma
- Being tested
- telemonitoring, Spirometry (baseline), Spirometry (20 - 22weeks), Teleconsultation
- Keywords
- telemedicine, asthma control test, Primary Health care, spirometry
- Medical subject headings
- Asthma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
telemonitoringOther
Patients is evaluated by telemonitoring (phone call nurse - 45 and 90 days).
Spirometry (baseline)Other
Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks.
Spirometry (20 - 22weeks)Other
Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks.
TeleconsultationOther
The general practioner received phone call to asthma care.
| Study group | Role | What they receive |
|---|---|---|
| Control | Active comparator | Spirometry (baseline) Spirometry (20 - 22weeks) Receives: Other: Spirometry (baseline); Other: Spirometry (20 - 22weeks) |
| Telemedicine | Experimental | Spirometry (baseline) Telemonitoring Teleconsultation Spirometry (20 - 22weeks) Receives: Other: telemonitoring; Other: Spirometry (baseline); Other: Spirometry (20 - 22weeks); Other: Teleconsultation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Symptoms control
Asthma Control Test (difference three points in the questionnaire ACT)
Measured: 20 to 22 weeks
Secondary outcomes (2)
Spirometry FVC
Spirometry parameters - FVC (forced vital capacity)
Measured: 20 to 22 weeks
Spirometry FEV1
Spirometry parameters - FEV 1 (forced expiratory volume in one second)
Measured: 20 to 22 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2016 (estimated)
- Study startMay 2015
- Primary completionJul 2017 (estimated)
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AsthmaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital de Clinicas de Porto Alegre
- Sponsor type
- University, hospital or other
- Collaborators
- Federal University of Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Prefeitura Municipal de Porto Alegre, Ministry of Health, Brazil
- Responsible party
- Sponsor
- Investigators
- Erno Harzheim, PhD, Principal investigator, Federal University of Rio Grande do Sul
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02901522
- Sponsor's protocol ID
- 227190 Asthma
- Acronym
- RESPIRANET-A
- Status last verified
- Jan 2017
- First submitted
- 12 Sep 2016
- Last updated
- 18 Jan 2017
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness.
- ClinicalTrials.gov ID
- NCT02901522
- Acronym / sponsor ID
- RESPIRANET-A / 227190 Asthma
- Conditions
- Asthma
- Keywords
- telemedicine, asthma control test, Primary Health care, spirometry
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Hospital de Clinicas de Porto AlegreUniversity, hospital or other
- Collaborators
- Federal University of Rio Grande do Sul, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Prefeitura Municipal de Porto Alegre, Ministry of Health, Brazil
- Study start
- May 2015
- Primary completion
- Jul 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 15 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with asthma.
Detailed description
This study is a randomized clinical trial for patients with asthma from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of asthma symptoms.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control | Active comparator | Other: Spirometry (baseline), Other: Spirometry (20 - 22weeks)Spirometry (baseline) Spirometry (20 - 22weeks) |
| Telemedicine | Experimental | Other: telemonitoring, Other: Spirometry (baseline), Other: Spirometry (20 - 22weeks), Other: TeleconsultationSpirometry (baseline) Telemonitoring Teleconsultation Spirometry (20 - 22weeks) |
Who may qualify
- Ages
- 12 to 100 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- individual with diagnosis asthma, Asthma Control Test <20, spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster)
Key exclusion criteria (1 listed)
- -low quality spirometries (inadequate)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| telemonitoringPatients is evaluated by telemonitoring (phone call nurse - 45 and 90 days). | Other | Telemedicine |
| Spirometry (baseline)Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks. | Other | Control, Telemedicine |
| Spirometry (20 - 22weeks)Patients is evaluated by Asthma Control Test and spirometry at baseline and after 20 weeks. | Other | Control, Telemedicine |
| TeleconsultationThe general practioner received phone call to asthma care. | Other | Telemedicine |
Primary outcome
Symptoms control
Time frame: 20 to 22 weeks
Asthma Control Test (difference three points in the questionnaire ACT)
2 secondary outcomes
Spirometry FVC
Time frame: 20 to 22 weeks
Spirometry FEV1
Time frame: 20 to 22 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Asthma
RecruitingObservational study
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Asthma Bronchial
RecruitingPhase 3
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Asthma
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingPhase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Active, not recruitingPhase 1
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Erno Harzheim, PhD principal investigator
Federal University of Rio Grande do Sul
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing telemonitoring, Spirometry (baseline) and Spirometry (20 - 22weeks) in people with Asthma, run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 18 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Marcelo R. Gonçalves, PhD (5191175156 ext. +55, marcelorog@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Symptoms control (time frame: 20 to 22 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2017.